15 Results for "

GLS2

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "GLS2" in MCE Product Catalog:

110
110 Cited Publications
Art. -Nr.: HY-12248
CAS. Nr.: 1439399-58-2
Reinheit:  99.82%
Synonyms: CB-839
Target:  

Glutaminase Autophagy

Forschungsgebiete:  

Cancer

Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity .
loading...
    loading...
110
110 Cited Publications
Art. -Nr.: HY-12248A
CAS. Nr.: 1874231-60-3
Synonyms: CB-839 hydrochloride
Target:  

Glutaminase Autophagy

Forschungsgebiete:  

Cancer

Telaglenastat (CB-839) hydrochloride is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat hydrochloride selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat hydrochloride inudces autophagy and has antitumor activity .
loading...
    loading...
Art. -Nr.: HY-103671
CAS. Nr.: 1853164-83-6
Reinheit:  99.47%
Target:  

Glutaminase

Forschungsgebiete:  

Inflammation/Immunology Cancer

IPN-60090 is an orally active and highly selective inhibitor of glutaminase 1 (GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 can be used for solid tumors research, such as lung and ovarian cancers [2].
loading...
    loading...
Art. -Nr.: HY-103671A
CAS. Nr.: 2102101-72-2
Reinheit:  99.68%
Target:  

Glutaminase

Forschungsgebiete:  

Inflammation/Immunology Cancer

IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 (GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 dihydrochloride can be used for solid tumors research, such as lung and ovarian cancers [2].
loading...
    loading...
Art. -Nr.: HY-P2760
CAS. Nr.: 9001-47-2
Synonyms: GLS
Forschungsgebiete:  

Cancer

Glutaminase is a metabolic enzyme. Glutaminase catalyzes the hydrolysis of glutamine to glutamate. Glutaminase isoenzymes are encoded by Gls and Gls2 genes. Proteins GLS and GLS2 have different kinetic, immunologic, and molecular characteristics. Glutaminase can be used in the research of cancer [2].
loading...
    loading...
Art. -Nr.: HY-12248R
CAS. Nr.: 1439399-58-2
Synonyms: CB-839 (Standard)
Forschungsgebiete:  

Cancer

Telaglenastat (Standard) is the analytical standard of Telaglenastat. This product is intended for research and analytical applications. Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity .
loading...
    loading...
Art. -Nr.: HY-RS05503
Forschungsgebiete:  

Others

GLS2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Art. -Nr.: HY-RS17808
Forschungsgebiete:  

Others

Gls2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gls2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Art. -Nr.: HY-RS24276
Forschungsgebiete:  

Others

Gls2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Gls2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Art. -Nr.: HY-151434
CAS. Nr.: 3033615-55-0
Target:  

Glutaminase Apoptosis

Forschungsgebiete:  

Cancer

GLS1 Inhibitor-6 (Compound 24y) is an orally active, potent and selective glutaminase 1 (GLS1) inhibitor (IC50=68 nM), shows 220-fold selectivity for GLS2. GLS1 Inhibitor-6 shows good anti-tumor activity, antitumor cell proliferation activity and induces apoptosis .
loading...
    loading...
Art. -Nr.: HY-P88072
Synonyms: GA; GLS; hLGA; LGA

Host:  

Mouse

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Art. -Nr.: HY-P88072A
Synonyms: GA; GLS; hLGA; LGA

Host:  

Mouse

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Art. -Nr.: HY-P87274
Synonyms: breast cell glutaminase antibody; GA antibody; GLS antibody; GLS2 antibody; GLSL_HUMAN antibody; glutaminase 2 (liver mitochondrial) antibody; glutaminase 2 antibody; glutaminase GA antibody; glutaminase I antibody; Glutaminase liver isoform antibody

Host:  

Mouse

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Art. -Nr.: HY-103671AR
CAS. Nr.: 2102101-72-2
Forschungsgebiete:  

Inflammation/Immunology Cancer

IPN60090 dihydrochloride (Standard) is the analytical standard of IPN60090 dihydrochloride (HY-103671A). This product is intended for research and analytical applications. IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 (GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 dihydrochloride can be used for solid tumors research, such as lung and ovarian cancers [2].
loading...
    loading...
Art. -Nr.: HY-103671R
CAS. Nr.: 1853164-83-6
Forschungsgebiete:  

Inflammation/Immunology Cancer

IPN60090 (Standard) is the analytical standard of IPN60090 (HY-103671). This product is intended for research and analytical applications. IPN-60090 is an orally active and highly selective inhibitor of glutaminase 1 (GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 can be used for solid tumors research, such as lung and ovarian cancers [2].
loading...
    loading...
  • 1